Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Gainsharing Does Not Equal Device Contracting Arrangements, CMS Says

This article was originally published in The Gray Sheet

Executive Summary

Cost-saving measures associated with gainsharing programs are not limited to product standardization and device contracting arrangements as many in the device industry fear, according to Mark Wynn, who heads the payment policy demonstration project division at CMS

You may also be interested in...



Study Finds Health Spending Growth Has Been Beneficial, But Cites Concerns

Quelling the growth of federal healthcare costs has been a popular U.S. policy objective for some time, but Harvard and University of Michigan researchers find in a recent study that substantial medical spending increases over the past 40 years have largely paid off

Study Finds Health Spending Growth Has Been Beneficial, But Cites Concerns

Quelling the growth of federal healthcare costs has been a popular U.S. policy objective for some time, but Harvard and University of Michigan researchers find in a recent study that substantial medical spending increases over the past 40 years have largely paid off

Premier Touts Better Patient Outcomes, Savings Under Pay-For-Performance

Financially inducing hospitals to improve care for heart bypass patients can drastically reduce hospital stays and readmissions, according to preliminary results from a national pay-for-performance initiative co-developed by the Premier group purchasing organization and CMS

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT023675

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel